Abemaciclib with endocrine therapy in the treatment of high-risk early breast cancer: ASCO optimal adjuvant chemotherapy and targeted therapy guideline rapid …

SH Giordano, RA Freedman, MR Somerfield… - Journal of Clinical …, 2022 - ascopubs.org
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline …

TTGE Panel - Journal of Clinical Oncology, 2022 - mdanderson.elsevierpure.com
Abstract ASCO Rapid Recommendations Updates highlight revisions to select ASCO
guideline recommendations as a response to the emergence of new and practice-changing …

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline …

SH Giordano, RA Freedman… - Journal of Clinical …, 2021 - europepmc.org
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline …

TTGE Panel - Journal of Clinical Oncology, 2022 - pure.johnshopkins.edu
Abstract ASCO Rapid Recommendations Updates highlight revisions to select ASCO
guideline recommendations as a response to the emergence of new and practice-changing …

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline …

SH Giordano, RA Freedman… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …